Whats new
Whats new.
Baird - Efti Continues to Look More Promising than Anti-Tigit in ESMO Abstract; Rated OP, $7 tgt (Analyst: Joel L. Beatty, MD, CFA)
October 17th 2023
For a copy of this research report please contact your Baird advisor
Whats new
October 17th 2023
For a copy of this research report please contact your Baird advisor